Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 89,232 | 78,462 | N/A | N/A |
| Marketable Securities | 3,503 | 27,589 | N/A | N/A |
| TOTAL | $93,745 | $106,926 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 7,142 | 6,027 | N/A | N/A |
| Other Non-Current Assets | 211 | 154 | 0 | 0 |
| TOTAL | $7,353 | $6,181 | $N/A | $N/A |
| Total Assets | $101,098 | $113,107 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,778 | 1,845 | 0 | 0 |
| Accrued Expenses | 2,641 | 1,557 | N/A | N/A |
| TOTAL | $8,419 | $4,702 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 475 | 567 | N/A | N/A |
| Other Non-Current Liabilities | 226 | 142 | 0 | 0 |
| TOTAL | $701 | $709 | $N/A | $N/A |
| Total Liabilities | $9,120 | $5,411 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -192,001 | -104,298 | N/A | N/A |
| Other shareholders' equity | 269,102 | 201,087 | 0 | 0 |
| TOTAL | $91,978 | $107,696 | $N/A | $N/A |
| Total Liabilities And Equity | $101,098 | $113,107 | $0 | $0 |